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a b s t r a c t
Axial gout can affect all segments of the spine. It is manifested as back pain, as pain associ-
ated with neurological symptoms, and as neurological impairment without pain in 17.9%, 
75.8% and 4.2% of cases, respectively. These manifestations were the fi rst presentation of 
gout in many patients. Although X-rays as well as computed tomography and especially 
magnetic resonance scans can be very suggestive, histopathological, cytological and crystal 
analyses are the diagnostic gold standard. In most cases involving neurological manifesta-
tions, the patient underwent surgery, leading to satisfactory results. There are, however, 
some reports of full recovery following the usual clinical treatment for gout, suggesting 
that such treatment may be the initial option for those subjects with a history of gout and 
radiological fi ndings of axial involvement.
© 2013 Elsevier Editora Ltda. All rights reserved.
Gota axial
Palavras-chave:
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r e s u m o
A gota axial pode afetar todos os segmentos da coluna vertebral. Ela se manifesta como 
dor nas costas, dor associada com sintomas neurológicos, e como comprometimento neu-
rológico sem dor em 17,9%, 75,8% e 4,2% dos casos, respectivamente. Essas manifestações 
foram a primeira apresentação da gota em muitos pacientes. Embora radiografi as, bem 
como tomografi a computadorizada e especialmente ressonância magnética, possam ser 
muito sugestivos, análises histopatológicas, citológicas e pesquisa de cristais são o padrão 
ouro de diagnóstico. Na maioria dos casos que envolveram manifestações neurológicas, o 
paciente foi submetido à cirurgia, levando a resultados satisfatórios. Há, no entanto, alguns 
relatos de recuperação total após o tratamento clínico habitual para gota, o que sugere que 
esse tratamento pode ser a opção inicial para os indivíduos com histórico de gota e sinais 
radiológicos de envolvimento axial.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
Spinal gout was fi rst described by Kersley et al.1 in 1950, and 
in 1953 Koskoff et al.2 reported the fi rst case of myelopathy 
due to gout. Since then, several cases of spinal gout have been 
reported, with manifestations ranging from an asymptomatic 
clinical picture to serious complications, such as paraplegia 
and quadriparesis (see Table 1 with case reports cited). This 
study reviews the literature related to clinical manifestations, 
diagnosis and treatment of spinal involvement due to gout.
Methods
A bibliographical search for the terms spine, gout, tophus, and 
myelopathy was carried out on PubMed and Medline, and a 
selection of articles describing spinal gout, including case re-
ports, letters to the editor, radiological fi ndings, systematic 
reviews and observational trials was made. Cross-referencing 
cases among these reports, that were absent in initial search, 
were also included in the current review. The fi nal number of 
articles was 94, and a total of 113 subjects were included in 
these reports. Our search also found two larger studies regard-
ing axial gout and radiological image, one with a retrospective 
design and the other one being a prospective study. No previ-
ous reviews regarding this subject included these two studies, 
and neither had such a comprehensive search for case reports. 
Results
Clinical manifestations
The mean age of the 113 patients was 60.3 ± 14.4 years ranging 
from 17 to 85 years,3,4 and 70.8% were male. A previous history 
of gout was observed in 62 patients (65.9% of the reports that 
mentioned this information), and 31 of them were tophaceous. 
There was no reference to a history of hyperuricemia and/or 
gout in 19 (16.8%) patients. 
Serum uric acid was measured at the diagnosis in 69 pa-
tients and 48 (69.6%) presented with high levels. Renal insuf-
fi ciency was reported in 25 cases (22.1%) and a previous his-
tory of renal transplant in another 7 (6.2%).4-6 Alcohol use and 
diuretic regimen was reported only in 7 (6.2%) and 12 (10.6%) 
cases, respectively.
Spinal involvement was the initial manifestation of gout in 
28 patients (24.8%). All spinal segments were affected: the lum-
bar spine in 66 of the 113 patients (58.4%); the cervical spine 
in 28 (24.8%); and the thoracic spine in 24 (21.2%). The involve-
ment of S1 was observed in 15 cases (13.3%), associated with 
lumbar spine lesions in 13 (86.7%) of them. Two patients (1.8%) 
had both cervical and thoracic lesions,7,8 and another four 
(3.5%) had simultaneous thoracic and lumbar involvement.5,9-11
Gout may affect any spinal structure, such as intervertebral 
discs, facet joints, laminae, vertebral bodies, pedicles, ligamen-
tum fl avum, fi lum terminale and the soft tissues adjacent to 
the spinal column.12
Neurological symptoms were observed in 88 patients 
(77.9%), and there was an association with cervical, thoracic or 
lumbar pain in 80 (90.9%) of these cases. Pain with no neuro-
logic symptom was reported in 23 patients (20.4%), 3 (2.7%) 
in the cervical spine, 1 (0.9%) in the thoracic spine, 20 (17.7%) 
in the lumbar spine (one case with both cervical and lumbar 
pain, and one report with both lumbar and thoracic involve-
ment) and 1 (0.9%) with pain over the sacrum. Two (1.8%) pa-
tients were asymptomatic and were only diagnosed on au-
topsy (Table 2).13,14
Radiculopathy (motor dysfunction or dysesthesia along 
the course of a specifi c nerve caused by compression of its 
root) was the most frequent neurological symptom, occurring 
in 39 patients (34.5%), followed by claudication in 23 (20.4%), 
crural paraparesis in 14 (12.4%), quadriparesis in 8 (7.1%), 
and paraplegia in 5 (4.4%). Atlanto-axial subluxation with the 
presence of tophus was observed in two cases of cervical pain 
leading to quadriparesis,15,16 and in one case of multiple cra-
nial nerves palsy.17 Neurologic symptoms without pain were 
related in 8 patients (7.1%).
Bladder and/or bowel dysfunction was observed in 10 sub-
jects, all of them presenting with other neurological mani-
festations, and 5 with back pain. Thirty-four (38.6%) of the 88 
cases with neurological impairment exhibited acute onset of 
symptoms (four weeks or less prior to diagnosis).
Fever higher than 38 °C was reported in 15 patients (10.6%), 
all of them with elevated erythrocyte sedimentation rate 
(ESR) and C reactive protein; therefore, exclusion of an infec-
tious process was mandatory. Additionally, further 12 cases 
without fever had elevated ESR.
Imaging studies
As observed by King et al.,18 X-rays may be normal or reveal 
soft tissue edema, signs compatible with osteoarthritis (new 
bone formation and/or reduction of intervertebral space), 
clearly-defi ned subchondral bone cysts, erosions with scle-
rotic borders, erosion of the odontoid process, atlanto-axial 
subluxation and pathologic fracture.18,19 Among the fi ndings 
listed above, the most common were those suggestive of os-
teoarthritis, seen in 26 (65%) of the 40 reports in which a spi-
nal radiography was described. Fig. 1 shows a thoracic radiog-
raphy of a patient followed at our clinic due to longstanding 
gout and thoracic (T7) spinal involvement.
Although not frequently mentioned in the literature, com-
puted tomography may show erosions located in facet joints20 
and damage to soft tissue with the presence of low-density 
nodule or mass in some cases.21
In magnetic resonance imaging (MRI), tophaceous gout is 
usually characterized by a homogeneous image with a signal 
ranging from intermediate to low on T1 (with the same signal 
intensity as muscle), and on T2, the image appears homoge-
neous and may show low or high intensity.22-25 When contrast 
(gadolinium) is used, peripheral heterogeneous or homoge-
neous contrast enhancement may occur, revealing reactive 
vascularization.22,26 Fig. 2 shows the MRI of the lumbar spine 
of the same patient described above.
The tophus does not present a characteristic image and 
so it is diffi cult to differentiate it from other types of lesion, 
such as neoplasms, infections and abscesses. As a result, the 
fi nal diagnosis often requires histopathological or cytological 
analyses.
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Table 1 – Spinal gout case reports and series reviewed but not cited in the text.
No. Authors No. of cases 
reported
Year Reference 
1 Adenwalla HN, Usman MH, Bagir M et al. 1 2007 South Med J. 2007 Apr;100(4):413-4
2 Arnold MH, Brooks PM, Savvas P et al. 1 1988 Aust N Z J Med. 1988 Dec;18(7):865-7
3 Barrett K, Miller ML, Wilson JT 1 2001 Neurosurgery. 2001 May;48(5):1170-2
4 Beier CP, Hartmann A, Woertgen C et al. 1 2005 J Neurosurg Spine. 2005 Dec;3(6):485-7
5 Bonaldi VM, Duong H, Starr MR et al. 1 1996 AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1949-52
6 Burnham J, Fraker K, Steinbach H 1 1977 AJR Am J Roentgenol. 1977 Dec;129(6):1116-9
7 Cabot J, Mosel L, Kong A et al. 1 2005 Skeletal Radiol. 2005 Dec;34(12):803-6
8 Chan AT, Leung JL, Sy AN 1 2009 Hong Kong Med J. 2009 Apr;15(2):143-5
9 Chang IC 4 2005 Clin Orthop Relat Res. 2005 Apr(433):106-10
10 Clerc D, Marfeuille M, Labous E et al. 1 1998 Clin Exp Rheumatol. 1998 Sep-Oct;16(5):621
11 Das De S 1 1988 J Bone Joint Surg Br. 1988 Aug;70(4):671
12 Dhote R, Roux FX, Bachmeyer C et al. 1 1997 Clin Exp Rheumatol. 1997 Jul-Aug;15(4):421-3
13 Diaz A, Porhiel V, Sabatier P 1 2003 Neurochirurgie. 2003 Dec;49(6):600-4
14 Draganescu M, Leventhal LJ 1 2004 J Clin Rheumatol. 2004 Apr;10(2):74-9
15 Duprez TP, Malghem J, Vande Berg BC et al. 1 1996 AJNR Am J Neuroradiol. 1996 Jan;17(1):151-3
16 El Sandid M, Ta H 1 2004 Ann Intern Med. 2004 Apr 20;140(8):W32
17 Ferreira A, Silva Junior BA, Braga FM et al. 1 1989 Arq Neuropsiquiatr. 1989 Dec;47(4):479-83
18 Fontenot A, Harris P, Macasa A et al. 1 2008 J Clin Rheumatol. 2008 Jun;14(3):188-9
19 Gines R, Bates DJ. 1 1998 Am J Emerg Med. 1998 Mar;16(2):216
20 Hasegawa EM, Goldenstein-Schainberg C, Fuller R 1 2007 Rev Bras Reumatol. 2007 Jul-Aug;47(4):300-2
21 Jacobs SR, Edeiken J, Rubin B et al. 1 1985 Arch Phys Med Rehabil. 1985 Mar;66(3):188-90
22 Justiniano M, Colmegna I, Cuchacovich R 1 2007 J Rheumatol. 2007 May;34(5):1157-8
23 Kao MC, Huang SC, Chiu CT et al. 1 2000 J Formos Med Assoc. 2000 Jul;99(7):572-5
24 Kelly J, Lim C, Kamel M et al. 1 2005 J Neurosurg Spine. 2005 Feb;2(2):215-7
25 Kern A, Schunk K, Thelen M 1 1999 Rofo. 1999 May;170(5):515-7
26 Ko KH, Huang GS, Chang WC 1 2009 Arthritis Rheum. 2009 Jan;60(1):198
27 Ko KH, Huang GS, Chang WC 1 2010 J Clin Rheumatol. 2010 Jun;16(4):200
28 Ko PJ, Huang TJ, Liao YS et al. 1 1996 Changgeng Yi Xue Za Zhi. 1996 Sep;19(3):272-6
29 Lam HY, Cheung KY, Law SW et al. 4 2007 J Orthop Surg (Hong Kong). 2007 Apr;15(1):94-101
30 Leaney BJ, Calvert JM 1 1983 J Neurosurg. 1983 Apr;58(4):580-2
31 Lievre JA, Leroux-Robert J, Bacri J 1 1961 Presse Med. 1961 Jul 8;69:1525-6
32 Litvak J, Briney W 1 1973 J Neurosurg. 1973 Nov;39(5):656-8
33 Miller JD, Percy JS 1 1984 J Rheumatol. 1984 Dec;11(6):862-5
34 Niva M, Tallroth K, Konttinen YT 1 2006 Clin Exp Rheumatol. 2006 Jan-Feb;24(1):112
35 Nygaard HB, Shenoi S, Shukla S 1 2009 Neurology. 2009 Aug 4;73(5):404
36 Paquette S, Lach B, Guiot B 1 2000 Neurosurgery. 2000 Apr;46(4):986-8
37 Peeters P, Sennesael J 1 1998 Nephrol Dial Transplant. 1998 Dec;13(12):3245-7
38 Pfi ster AK, Schlarb CA, O'Neal JF 1 1998 AJR Am J Roentgenol. 1998 Nov;171(5):1430-1
39 Reynolds AF, Jr., Wyler AR, Norris HT 1 1976 Arch Neurol. 1976 Nov;33(11):795
40 Riddell CM, Elliott M, Cairns AP 1 2008 J Rheumatol. 2008 Oct;35(10):2076-7
41 Sabharwal S, Gibson T 1 1988 Br J Rheumatol. 1988 Oct;27(5):413-4
42 Saketkoo LA, Robertson HJ, Dyer HR et al. 1 2009 J Med Sci. 2009 Aug;338(2):140-6
43 Samuels J, Keenan RT, Yu R et al. 1 2010 Bull NYU Hosp Jt Dis. 2010;68(2):147-8
44 Sequeira W, Bouffard A, Salgia K et al. 1 1981 Arthritis Rheum. 1981 Nov;24(11):1428-30
45 Souza AW, Fontenele S, Carrete H et al. 1 2002 Clin Exp Rheumatol. 2002 Mar-Apr;20(2):228-30
46 St George E, Hillier CE, Hatfi eld R 1 2001 Rheumatology (Oxford). 2001 Jun;40(6):711-2
47 Staub-Schmidt T, Chaouat A, Rey et al. 1 1995 Arthritis Rheum. 1995 Jan;38(1):139-41
48 Suk KS, Kim KT, Lee SH et al. 1 2007 Spine J. 2007 Jan-Feb;7(1):94-9
49 Tkach S 1 1970 Clin Orthop Relat Res. 1970;71:81-6
50 Vaccaro AR, An HS, Cotler JM et al. 1 1993 Orthopedics. 1993 Nov;16(11):1273-6
51 van de Laar MA, van Soesbergen RM, Matricali B 1 1987 Arthritis Rheum. 1987 Feb;30(2):237-8
52 Varga J, Giampaolo C, Goldenberg DL 1 1985 Arthritis Rheum. 1985 Nov;28(11):1312-5
53 Vervaeck M, De Keyser J, Pauwels P et al. 1 1991 Clin Neurol Neurosurg. 1991;93(3):233-6
54 Vinstein AL, Cockerill EM 1 1972 Radiology. 1972 May;103(2):311-2
55 Wald SL, McLennan JE, Carroll RM et al. 1 1979 J Neurosurg. 1979 Feb;50(2):236-9
56 Wang LC, Hung YC, Lee EJ et al. 1 2001 J Formos Med Assoc. 2001 Mar;100(3):205-8
57 Yasuhara K, Tomita Y, Takayama A et al. 1 1994 J Spinal Disord. 1994 Feb;7(1):82-5
58 Yen HL, Cheng CH, Lin JW 1 2002 Acta Neurochir (Wien). 2002 Feb;144(2):205-7
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The most common fi ndings in imaging study are listed in 
Table 3.
Diagnosis
In 103 of the 113 cases (91.2%), a diagnosis was achieved 
through cytological or histopathological studies. A histologi-
cal study of the tissue removed during the surgical excision 
of the lesion or decompressive laminectomy was performed 
in 87 patients (77%). Guided puncture was done in 16 patients 
(14.2%), biopsy being unnecessary; and an open biopsy was 
performed in one (0.9%).27 A pasty, chalky-white mass was 
usually observed during the surgery.
In seven patients (6.2%),8,17,23,24,28-30 histological or cytologi-
cal tests were not performed, and diagnosis was presumed 
based on clinical and imaging fi ndings or on arthrocentesis of 
A B
C
Fig. 1 – (A and B) MRI of thoracic spine on lateral 
view. Note the presence of a low signal lesion in T1 
indicated by the arrows (A) before and (B) after contrast 
administration, with a homogeneous enhancement. 
(from: Hasegawa EM, Goldenstein-Schainberg C, Fuller 
R. Rev Bras Reumatol. 2007;47(4):300-2). (C) Lateral 
radiography of cervical spine in a patient with chronic 
tophaceous gout. The arrows show erosions in the 
anterior aspects of the vertebral bodies.
other joints. In another four cases (3.5%) diagnosis was made 
during autopsy,1,2,13,14 but none of them died because of spinal 
involvement by gout.
In 17 patients who reported pain without neurological 
manifestation, guided puncture or surgical intervention was 
performed based on the presence of abnormalities in CT and/
or MRI (mass lesion), and eventually fever and elevation in 
ESR at onset.
The histological description includes classic gout aspects, 
such as the presence of histiocytes and multinucleated giant 
cells and fi broblasts surrounding eosinophilic debris or amor-
phous material, and may contain needle-shaped crystals 
with negative birefringence under polarized light. Occasion-
ally, only the negative image of the crystals is observed in the 
neutrophils, as they are dissolved during fi xation in aqueous 
medium.31-33
Treatment
Among the 88 patients with neurological symptoms, 74 (84.1%) 
underwent surgery. The most common procedure was decom-
pressive laminectomy. Full recovery of neurological manifes-
tations was observed in 55 of 74 patients (74.3%); partial re-
covery followed surgery in nine, and two patients31,34 reported 
no recovery after surgery, although one of them34 improved 
after subsequent clinical treatment with non-steroidal anti-
infl ammatory (NSAIDs) and hypouricemic drugs. In another 
six cases there was no follow-up description and thus no data 
about response to surgery could be retrieved. Only one pa-
tient without neurological symptoms was managed surgically 
but there was no mention to outcomes. Two patients died in 
the post operatory status due to bronchopneumonia,15,28 one 
of them had not shown any improvement, while the other 
was actually getting better from the neurological symptoms 
before the infectious complication.
Twenty-fi ve patients (22.1%) received clinical treatment 
alone (NSAIDs, colchicines and oral, intravenous or epidural 
corticosteroid) with recovery from neurological defi cits and/
or pain. In three cases managed conservatively the outcome 
was not reported.6,23,35 Three patients who did not undergo 
surgery died from bronchopneumonia,1,9,17 one of them had 
been improving from the symptoms related to gout, whilst 
the other two had not. In eight cases there was no mention 
to management and outcome. Treatment outcomes are sum-
marized in Fig. 2.
Discussion 
Spinal involvement in gout arthritis is increasingly recog-
nized as an unusual manifestation; however its prevalence 
is clearly underestimated because only those patients with 
neurological defi cits and/or fever, and those who do not im-
prove with clinical treatment are investigated with imaging 
and subsequent histopathological studies to confi rm the di-
agnosis.
Although considered to be a rare manifestation of gout, 
mainly because most of the cases reported are of symptom-
atic clinical scenarios (98.2% of the 113 patients reviewed in 
this article), some evidence point out to the fact that spinal 
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Fig. 2 – Treatment and outcome summary. 
Total recovery 
(n = 55)
Surgical treatment 
(n = 75)
Spinal gout
(n = 113)
Autopsy
(n = 2)
Clinical treatment 
(n = 30)
Treatment and unknown 
outcome (n = 8)
(66.4%)
(26.6%)
(7.1%)
(0.9%)
(22.1%)
(1.8%)
(2.7%)
(6.2%)
(1.8%)
(1.8%)
(8.0%)
(48.7%)
Death due to
bronchopneumonia (n = 1)
Partial improvement 
(n = 9)
No response
(n = 2)
Death due to postoperative
complication  (n = 2)
Unknown outocome
(n = 7)
Unknown outcome
(n = 3)
Death due to 
bronchopneumonia (n = 2)
Improvement
(n = 25)
Table 2 – Clinical manifestations.
Symptoms n %
Neurologic defi cit with back pain 80
Radiculopathy 39 34.5
Claudication 23 20.4
Paraparesis 14 12.4
Tetraparesis 8 7.1
Paraplegia 5 4.4
Pain without neurologic defi cit 23 20.4
Cervical 3 2.7
Thoracic 1 0.9
Lumbar 20 17.7
Sacral 1 0.9
Neurologic defi cit only 8 7.1
Unknown* 2 1.8
* Diagnosis made by autopsy
Table 3 – Imaging fi ndings in spinal gout.
Method Findings
X – Ray Osteoarthritic changes: osteophytes, subchondral 
cysts and bony sclerosis
CT Osteoarthritic changes
Low-density mass
Facet joint erosion
MRI T1 – homogeneous, low to intermediate signal
T2 – homogeneous, low to high signal
Contrast (Gadolinium): homogeneous, peripheral 
enhancement
Normal bone marrow signal of the adjacent 
vertebrae
CT, computed tomography; MRI, magnetic resonance imaging.
alterations in gout might be much more common than previ-
ously thought. Konatalapalli et al.36 retrospectively reviewed 
64 CT images of the spine from patients with gout, and found 
out that 14% of them presented features of spinal gout. The 
same research group performed a prospective study in which 
48 subjects with a diagnosis of gout had a spinal CT scan.37 
Thirty-fi ve percent of the patients had CT scan evidence of 
spinal gout erosions or tophi. Since these two studies were 
not case reports and therefore did not mention any individual 
clinical info on each patient, they were not included in our 
analysis. 
Axial gout should be considered in the differential diag-
nosis of patients with previous diagnosis of gout or a history 
of hyperuricemia who present symptoms suggesting spinal 
cord involvement and lumbar or cervical pain. Although usu-
ally not mentioned in many case reports, risk factors for the 
development of acute gout such a as renal failure, drugs (di-
uretics, low-dose aspirin), diet, alcohol intake, and infection 
should also be considered for the presumptive diagnosis of 
spinal gout.
The mechanism associated with axial gout is not yet clear. 
However, it is assumed that the same factors leading to the 
peripheral picture such as pH, temperature, trauma and joint 
degeneration are involved in crystal deposits.33,38 Finally, the 
presence of spinal osteoarthritis perhaps also facilitates fur-
ther crystal deposition.
In patients with no history of gout or hyperuricemia, the 
diagnosis may be presumed from CT scan, MRI study, clinical 
and laboratorial fi ndings, previous medical history, and as-
sociated risk factors. Plain radiography is a relatively limited 
diagnostic resource.
Histological or cytological analysis is necessary for a defi -
nite diagnosis and to exclude infectious processes or neo-
plasms which may have similar clinical and imaging aspects, 
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especially in patients without history of gout and/or those 
with signs and symptoms of red fl ags for back pain. The sam-
ple should be preserved in alcohol to prevent urate crystals 
dissolution.33 
Patients without neurological involvement may initially be 
treated with NSAIDs, as indicated in acute gout attacks,39,40 
and subsequently with hypouricemic drugs. In the presence 
of neurological symptoms, clinical treatment may also be 
tried, as it leads to improvement in some patients. The favor-
able response to clinical treatment alone may suggest that 
the infl ammatory process, rather than a compression due to 
tophi itself, should be the main mechanism for the develop-
ment of symptoms.
In a previous review of spinal gout made by Hou et al.,22 af-
ter an initial clinical, laboratorial and imaging evaluation, bi-
opsy is suggested as defi nite diagnosis procedure. If there are 
progressive neurologic defi cits, surgery may be preferred. If 
biopsy confi rms the diagnosis of gout, conservative treatment 
may be tried, and when symptoms persist or recur after initial 
improvement, surgery must be performed. We recommend 
guided puncture rather than open biopsy in those patients 
without severe or progressive neurological involvement, and 
in those with pain as sole manifestation that did not improve 
with clinical treatment.
In conclusion, gout should be included in the differential 
diagnosis of acute spinal pain episodes, associated or not 
with neurological manifestations in patients with a history 
of gout and hyperuricemia. In the cases without or with mild 
to moderate neurological manifestations, we recommend 
guided puncture as initial diagnostic procedure, and conser-
vative treatment with NSAIDs and/or corticosteroids. Sur-
gery must be reserved for those patients with no improve-
ment or those with progressive neurologic defi cits, despite 
clinical treatment.
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